Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter in (CTO) Coronary Lesions

NCT01978860 is registered in ClinicalTrials.gov with Chanan Schneider as lead sponsor.

NCT NCT01978860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01978860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, First in Man Study to Evaluate the Safety and Performance of the NovaCross™ Micro-catheter in (CTO) Coronary Lesions
Lead sponsor
Chanan Schneider
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2013
Completion date
December 31, 2014
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic total occlusion of coronary artery